Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Cell-based Assays Market: By Products and Services: Consumables, Instruments, Software, Services; By Application: Drug Discovery, ADME Studies, Basic Research, Others; By End Use; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Cell-based Assays Market Outlook

The global cell-based assays market stood at a value of more than USD 6677 million in 2021. The market is further expected to grow at a CAGR of 14% in the forecast period of 2023-2028 to attain a value of over USD 14657 million by 2027.

 

Rising Demand for Drug Discovery to Spearhead the Growth of the Global Cell-based Assays Industry

Based on application, the drug discovery segment is predicted to hold a significant market share in the cell-based assays industry. This can be attributed to the increased demand for effective drugs and medications that can help in disease prevention and the treatment of any morbidities associated with chronic illnesses, such as cancer and cardiovascular diseases. The experiments help generate complex and biologically relevant data. This is anticipated to drive the demand for cell-based assays in drug discovery applications in the forecast period.

 

Global Cell-based Assays Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America to Offer Lucrative Opportunities for the Global Cell-based Assays Industry Growth

North America is estimated to hold a substantial share of the cell-based assays industry in the forecast period. This can be attributed to the availability of advanced medical services, healthcare facilities, and technologies in the region. In addition, the growing prevalence of chronic diseases is leading to increased research trials and studies to analyse effective methods for disease treatment, which is expected to bolster the market growth in the coming years. Meanwhile, the Asia Pacific is also expected to account for a considerable market share owing to the growing investments in research and development activities by the leading pharmaceutical and biotechnology companies in the region.

 

Cell-based Assays: Market Segmentation

Cell-based assays refer to assays or experiments that are conducted within a living cell for various purposes. For instance, these assays can help analyse whether a chemical or material is cytotoxic. In addition, they also help in testing the potency of drugs based on their biological activity and are also used in immunogenicity studies, among others.

By products and services, the market is divided into:

  • Consumables
    • Reagents 
    • Microplates 
    • Probes and Labels
    • Assay Kits 
    • Cell Lines 
    • Others
  • Instruments 
  • Software
  • Services

On the basis of application, the market can be segmented into:

  • Drug Discovery 
  • ADME Studies
  • Basic Research 
  • Predictive Technology 
  • Others

Based on end use, the industry can be segregated into:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Government Research Institutes
  • Contract Research Organisations (CROs)
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Rising Incidences of Chronic Disorders and the Growing Clinical Trials to Augment the Global Cell-based Assays Industry

The rising incidences of severe diseases and ailments, such as cancer, cardiovascular diseases, diabetes, osteoarthritis, and others, are expected to bolster the demand for efficient drugs and vaccinations. This is expected to drive the demand for cell-based assays in drug discovery trials and research activities, thus, aiding the market growth. This is further supported by the rising geriatric population worldwide, which is more susceptible to chronic diseases and illnesses. As a result, the growing government investments in the medical sector are also predicted to drive the demand for cell-based assays in the forecast period. Furthermore, cell-based assays offer tissue specific responses compared to biochemical assays and are faster and cost-effective. This, in turn, is compelling pharmaceutical and biotechnology companies to increasingly adopt cell-based assays over biochemical assays. This is estimated to aid the industry growth in the coming years.

 

Key Industry Players in the Global Cell-based Assays Market

The report gives a detailed analysis of the following key players in the global cell-based assays market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Lonza Group Ltd.
  • PerkinElmer, Inc.
  • Promega Corporation
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical
and Forecast Market Analysis by Segment- Products and Services, Application, End Use, Region
Breakup by Products and Services Consumables, Instruments, Software, Services
Breakup by Application Drug Discovery, ADME Studies, Basic Research, Predictive Technology, Others
Breakup by End Use Pharmaceutical and Biotechnology Companies, Academic and Government Research Institutes, Contract Research Organisations (CROs), Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Lonza Group Ltd., PerkinElmer, Inc., Promega Corporation, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Cell-based Assays Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Cell-based Assays Historical Market (2018-2022) 
    8.3    Global Cell-based Assays Market Forecast (2023-2028)
    8.4    Global Cell-based Assays Market by Products and Services
        8.4.1    Consumables
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
            8.4.1.4    Breakup by Type
                8.4.1.4.1    Reagents
                8.4.1.4.2    Microplates
                8.4.1.4.3    Probes and Labels
                8.4.1.4.4    Assay Kits
                8.4.1.4.5    Cell Lines
                8.4.1.4.6    Others
        8.4.2    Instruments
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
        8.4.3    Software
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2018-2022)
            8.4.3.3    Forecast Trend (2023-2028)
        8.4.4    Services
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2018-2022)
            8.4.4.3    Forecast Trend (2023-2028)
    8.5    Global Cell-based Assays Market by Application
        8.5.1    Drug Discovery
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
        8.5.2    ADME Studies
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028)
        8.5.3    Basic Research
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2018-2022)
            8.5.3.3    Forecast Trend (2023-2028)
        8.5.4    Predictive Technology
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2018-2022)
            8.5.4.3    Forecast Trend (2023-2028)
        8.5.5    Others
    8.6    Global Cell-based Assays Market by End Use
        8.6.1    Pharmaceutical and Biotechnology Companies
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2018-2022)
            8.6.1.3    Forecast Trend (2023-2028)
        8.6.2    Academic and Government Research Institutes
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2018-2022)
            8.6.2.3    Forecast Trend (2023-2028)
        8.6.3    Contract Research Organisations (CROs)
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2018-2022)
            8.6.3.3    Forecast Trend (2023-2028)
        8.6.4    Others
    8.7    Global Cell-based Assays Market by Region       
        8.7.1    North America
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2018-2022) 
            8.7.1.3    Forecast Trend (2023-2028)
        8.7.2    Europe
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2018-2022) 
            8.7.2.3    Forecast Trend (2023-2028)
        8.7.3    Asia Pacific
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2018-2022) 
            8.7.3.3    Forecast Trend (2023-2028)
        8.7.4    Latin America
            8.7.4.1    Market Share
            8.7.4.2    Historical Trend (2018-2022) 
            8.7.4.3    Forecast Trend (2023-2028)
        8.7.5    Middle East and Africa
            8.7.5.1    Market Share
            8.7.5.2    Historical Trend (2018-2022) 
            8.7.5.3    Forecast Trend (2023-2028) 
9    North America Cell-based Assays Market Analysis
    9.1    United States of America 
        9.1.1    Market Share
        9.1.2    Historical Trend (2018-2022) 
        9.1.3    Forecast Trend (2023-2028)
    9.2    Canada
        9.2.1    Market Share
        9.2.2    Historical Trend (2018-2022) 
        9.2.3    Forecast Trend (2023-2028)
10    Europe Cell-based Assays Market Analysis
    10.1    United Kingdom
        10.1.1    Market Share
        10.1.2    Historical Trend (2018-2022) 
        10.1.3    Forecast Trend (2023-2028)
    10.2    Germany
        10.2.1    Market Share
        10.2.2    Historical Trend (2018-2022) 
        10.2.3    Forecast Trend (2023-2028)
    10.3    France
        10.3.1    Market Share
        10.3.2    Historical Trend (2018-2022) 
        10.3.3    Forecast Trend (2023-2028)
    10.4    Italy
        10.4.1    Market Share
        10.4.2    Historical Trend (2018-2022) 
        10.4.3    Forecast Trend (2023-2028)
    10.5    Others
11    Asia Pacific Cell-based Assays Market Analysis
    11.1    China
        11.1.1    Market Share
        11.1.2    Historical Trend (2018-2022) 
        11.1.3    Forecast Trend (2023-2028)
    11.2    Japan
        11.2.1    Market Share
        11.2.2    Historical Trend (2018-2022) 
        11.2.3    Forecast Trend (2023-2028)
    11.3    India
        11.3.1    Market Share
        11.3.2    Historical Trend (2018-2022) 
        11.3.3    Forecast Trend (2023-2028)
    11.4    ASEAN
        11.4.1    Market Share
        11.4.2    Historical Trend (2018-2022) 
        11.4.3    Forecast Trend (2023-2028)
    11.5    Australia
        11.5.1    Market Share
        11.5.2    Historical Trend (2018-2022) 
        11.5.3    Forecast Trend (2023-2028)
    11.6    Others
12    Latin America Cell-based Assays  Market Analysis
    12.1    Brazil
        12.1.1    Market Share
        12.1.2    Historical Trend (2018-2022) 
        12.1.3    Forecast Trend (2023-2028)
    12.2    Argentina
        12.2.1    Market Share
        12.2.2    Historical Trend (2018-2022) 
        12.2.3    Forecast Trend (2023-2028)
    12.3    Mexico
        12.3.1    Market Share
        12.3.2    Historical Trend (2018-2022) 
        12.3.3    Forecast Trend (2023-2028)
    12.4    Others
13    Middle East and Africa Cell-based Assays Market Analysis
    13.1    Saudi Arabia
        13.1.1    Market Share
        13.1.2    Historical Trend (2018-2022) 
        13.1.3    Forecast Trend (2023-2028)
    13.2    United Arab Emirates
        13.2.1    Market Share
        13.2.2    Historical Trend (2018-2022) 
        13.2.3    Forecast Trend (2023-2028)
    13.3    Nigeria
        13.3.1    Market Share
        13.3.2    Historical Trend (2018-2022) 
        13.3.3    Forecast Trend (2023-2028)
    13.4    South Africa
        13.4.1    Market Share
        13.4.2    Historical Trend (2018-2022) 
        13.4.3    Forecast Trend (2023-2028)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Value Chain Analysis
16    Competitive Landscape

    16.1    Market Structure
    16.2    Company Profiles
        16.2.1    Becton, Dickinson and Company
            16.2.1.1    Company Overview
            16.2.1.2    Product Portfolio
            16.2.1.3    Demographic Reach and Achievements
            16.2.1.4    Certifications
        16.2.2    Bio-Rad Laboratories, Inc.
            16.2.2.1    Company Overview
            16.2.2.2    Product Portfolio
            16.2.2.3    Demographic Reach and Achievements
            16.2.2.4    Certifications
        16.2.3    Lonza Group Ltd.
            16.2.3.1    Company Overview
            16.2.3.2    Product Portfolio
            16.2.3.3    Demographic Reach and Achievements
            16.2.3.4    Certifications
        16.2.4    PerkinElmer, Inc.
            16.2.4.1    Company Overview
            16.2.4.2    Product Portfolio
            16.2.4.3    Demographic Reach and Achievements
            16.2.4.4    Certifications
        16.2.5    Promega Corporation
            16.2.5.1    Company Overview
            16.2.5.2    Product Portfolio
            16.2.5.3    Demographic Reach and Achievements
            16.2.5.4    Certifications
        16.2.6    Others
17    Key Trends and Developments in the Market


List of Key Figures and Tables

1.    Global Cell-based Assays Market: Key Industry Highlights, 2018 and 2028
2.    Global Cell-based Assays Historical Market: Breakup by Products and Services Type (USD Million), 2018-2022
3.    Global Cell-based Assays Market Forecast: Breakup by Products and Services Type (USD Million), 2023-2028
4.    Global Cell-based Assays Historical Market: Breakup by Application (USD Million), 2018-2022
5.    Global Cell-based Assays Market Forecast: Breakup by Application (USD Million), 2023-2028
6.    Global Cell-based Assays Historical Market: Breakup by End Use (USD Million), 2018-2022
7.    Global Cell-based Assays Market Forecast: Breakup by End Use (USD Million), 2023-2028
8.    Global Cell-based Assays Historical Market: Breakup by Region (USD Million), 2018-2022
9.    Global Cell-based Assays Market Forecast: Breakup by Region (USD Million), 2023-2028
10.    North America Cell-based Assays Historical Market: Breakup by Country (USD Million), 2018-2022
11.    North America Cell-based Assays Market Forecast: Breakup by Country (USD Million), 2023-2028
12.    Europe Cell-based Assays Historical Market: Breakup by Country (USD Million), 2018-2022
13.    Europe Cell-based Assays Market Forecast: Breakup by Country (USD Million), 2023-2028
14.    Asia Pacific Cell-based Assays Historical Market: Breakup by Country (USD Million), 2018-2022
15.    Asia Pacific Cell-based Assays Market Forecast: Breakup by Country (USD Million), 2023-2028
16.    Latin America Cell-based Assays Historical Market: Breakup by Country (USD Million), 2018-2022
17.    Latin America Cell-based Assays Market Forecast: Breakup by Country (USD Million), 2023-2028
18.    Middle East and Africa Cell-based Assays Historical Market: Breakup by Country (USD Million), 2018-2022
19.    Middle East and Africa Cell-based Assays Market Forecast: Breakup by Country (USD Million), 2023-2028
20.    Global Cell-based Assays Market Structure

Key Questions Answered in the Report

In 2021, the global cell-based assays market attained a value of more than USD 6677 million.

The market is projected to grow at a CAGR of 14% between 2023 and 2028.

The market is estimated to witness a healthy growth in the forecast period of 2023-2028 to reach over USD 14657 million by 2027.

The major drivers of the industry, such as the increased demand for cell-based assays in drug discovery, rising investments in the medical sector, rapid technological advancements, efficient drug testing efficiency offered by cell-based assays, and rising incidences of chronic illnesses, are expected to aid the market growth.

The key market trends guiding the growth of the industry include the growing research and development activities and the ongoing clinical trials.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The significant products and services are consumables, instruments, software, and services.

The major applications include drug discovery, ADME studies, basic research, predictive technology, and others.

The different end uses include pharmaceutical and biotechnology companies, academic and government research institutes, contract research organisations (CROs), and others.

The major players in the industry are Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Lonza Group Ltd., PerkinElmer, Inc., Promega Corporation, and others.

Analyst Review

The global cell-based assays market reached a value of more than USD 6677 million in 2021, driven by the rising incidences of chronic illnesses, such as cancer and cardiovascular diseases. Aided by the growing clinical trials worldwide, the market is expected to witness a healthy growth in the forecast period of 2023-2028, growing at a CAGR of 14%. The market is projected to reach over USD 14657 million by 2027.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By products and services, the market can be distributed into consumables, instruments, software, and services. On the basis of application, the industry can be segmented into drug discovery, ADME studies, basic research, predictive technology, and others. The industry can be categorised based on end use into pharmaceutical and biotechnology companies, academic and government research institutes, contract research organisations (CROs), and others. The major regional markets for cell-based assays are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Lonza Group Ltd., PerkinElmer, Inc., Promega Corporation, and others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER